Information on Sartorius preference shares (SRT3) and Sartorius ordinary shares (SRT) at a glance
|Ordinary share: DE0007165607 | Preference share: DE0007165631|
|Ordinary share: SRT | Preference share: SRT3|
MDAX | TecDAX | MSCI Germany Index | CDAX | Prime All-Share-Index | Technology All Share-Index | NISAX20 | STOXX Europe 600
XETRA | Frankfurt Main | Hanover | Hamburg | Berlin | Munich | Düsseldorf | Stuttgart
Oddo Seydler Bank AG | M.M. Warburg & Co.
First trading day
|July, 10, 1990; Issue price: Ordinary share DM 710 | |
Preference share DM 610
Number of shares
|74,880,000 no-par individual share certificates; |
thereof ordinary shares: 37,440,000 | preference shares: 37,440,000
Number of shares outstanding
Ordinary shares: 34,212,224 | Preference shares: 34,176,068
Post IPO Activities
|Paying and exchange agent for Sartorius AG shares|
Commerzbank AG (Neue Börsenstraße 1, 60487 Frankfurt am Main, Germany)
Sartorius AG is currently covered by 17 sell-side analysts. The following list shows their latest recommendations for Sartorius preference shares.
Hauck & Aufhäuser
Thomas J. Schießle
The analysts’ estimates listed above as examples are not based on research or analyses conducted by Sartorius AG, but rather exclusively on analyses, research, reports, recommendations or ratings of third parties. References to such recommendations and ratings are provided as convenience for readers and for non-binding informational purposes only. These references do not imply that Sartorius AG adopts, endorses or confirms in any way the recommendations, options, opinions, conclusions or estimates of analysts. In particular, analysts’ estimates do not constitute any investment advice given by Sartorius AG. None of the information provided is intended as an offer or encouragement to buy Sartorius shares or other financial instruments, nor is it an offer to purchase or sell.
Sartorius AG shall not assume any liability, in particular for the selection, topicality, quality, completeness or accuracy of the analysts’ estimates shown and, if any, of analysts’ recommendations. Any liability on the part of Sartorius AG for damages or losses incurred by third parties based on the information published on this website shall be excluded.
|Ordinary shares||Preference shares|
|Administered by an executor||~50%||Free float||~91%|
|Bio-Rad Laboratories Inc.||~34%||Treasury shares||~9%|
|Members of the familiy||~5%|
Information on shareholdings and shares in free float pursuant to Sections 33 et seq. of the German Securities Trading Act (WpHG). Reporting obligations refer only to voting shares and not to non-voting preference shares. For this reason, the shareholder structure disclosed for Sartorius preference shares does not contain any detailed information beyond the company’s treasury shares.